Multiple Myeloma
News
Cyclophosphamide after transplant reduced GVHD in myeloma patients
Anticancer agents may be more active after transplantation than before, researchers suggested.
Conference Coverage
New antibodies, drugs for refractory and relapsed myeloma are effective in patients over 65
MADRID – Patients with refractory/relapsed multiple myeloma had similar rates of progression-free survival whether they were younger than age 65...
Article
Rare Case of Orbital Involvement from Multiple Myeloma
An unusual case of orbital metastases, originating from multiple myeloma, challenges clinicians on diagnostic methods for proper treatment...
Clinical Topics & News
Multiple Myeloma: Updates on Diagnosis and Management
Two- and 3-drug treatment regimens and autologous stem cell transplants provide opportunities for longer term disease remission, though most...
Conference Coverage
Differential Response to Carfilzomib Based on Initial Therapy With Bortezomib in Multiple Myeloma
Abstract 48: 2017 AVAHO Meeting
News
Less lenalidomide may be more in frail elderly multiple myeloma patients
Starting patients on a reduced dose and increasing it gradually while monitoring carefully for adverse events, meant patients did not have to stop...
Article
The Prognostic Value of Circulating Plasma Cells in Multiple Myeloma
A meta-analysis of 11 different studies was performed to determine whether circulating plasma cells are useful in the prognosis of patients...
Article
A New ‘Triplet’ Treatment for Multiple Myeloma
A combination of 3 different types of inhibitors has recently been shown to be effective in the treatment of patients with multiple myeloma...
Clinical Topics & News
Multiple Myeloma: Updates on Diagnosis and Management
Two- and 3-drug treatment regimens and autologous stem cell transplants provide
opportunities for longer term disease remission, though most...
Clinical Topics & News
Diagnosing Gastric Plasmacytoma
Researchers rule out possible diagnoses with extensive process of elimination to correctly diagnose a rare cancer.